XML 28 R11.htm IDEA: XBRL DOCUMENT

INVENTORY

9 Months Ended

Sep. 30, 2013

5. INVENTORY

The components of biopolymer inventories are as follows:

	September 30, 2013		December 31, 2012
Raw materials	$	854	$	640
Work-in-process	12		2
Finished goods	2,534		2,562
Total inventory	$	3,400	$	3,204

At September 30, 2013 and December 31, 2012, included within finished goods are $104 and $257, respectively, of inventory that the Company has sold and shipped to customers for which the Company has not yet recognized revenue under its product revenue recognition policy. During the three and nine months ended September 30, 2013, the Company recorded a $46 and $317 charge to cost of product revenue for raw material and finished goods inventory, respectively, that it determined was unlikely to be sold or converted to future sellable product based on customer demand and current sales forecasts.

- Definition

The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.

+ References+ Details